A Premier Life Science Real Estate and Facility Management Provider
Neovantage Innovation Parks is home to leading Pharma and Life Sciences R&D companies. With 850,000 sq ft of world class, Grade ‘A’ leased and operational space and an additional 300,000 sq ft in development, Neovantage Innovation Parks is the largest private owner and operator of life sciences infrastructure in South Asia. Our campuses are diligently designed with recreational areas, large open spaces with greenery, and world-class amenities to enable collaboration and innovation between people and businesses.
The Neovantage Innovation Story
2016
Acquisition
Acquired from Alexandria, US based REIT.
2016
Building 900
Project completed and leased out to Laxai.
2018
Building 189
Construction started for Building 189, a BTS project for TCI.
2018
Building 9000
Acquired the property.
2019
Building 189
Project completed and handed over to TCI.
2019
Building 9000
53,000 sq ft - Phase 1 Completed and handed over to Syngene.
2020
Building 3600
Construction started for 180,000 Sq Ft of state of art multi-tenanted R&D Facility.
.jpg)
2021
Co-Investment
Lighthouse Canton and Ivanhoé Cambridge announce co-investment in Neovantage Innovation Parks.
2023
Building 3600
Project Completed.
Whether you are an entrepreneur looking to make a difference in society or the CEO of a large MNC striving to stay ahead, Neovantage Innovation Parks is your ultimate destination for unlocking new discoveries.
Vision
Be the most admired real estate brand enabling accelerated innovation towards a better world.
Mission
To consistently deliver inspiring spaces and solutions with utmost focus on customer delight.
Mr. Subrata Sharma
Executive Director & Chief Executive Officer at Lighthouse Canton Real Estate
